Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
AuthID
P-002-Q77
P-002-Q77
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service